Document is current
Any future updates will be listed below
-
Authors
Takeuchi, Masato https://orcid.org/0000-0002-2990-2687
Shinkawa, Kanna
Yanagita, Motoko
Kawakami, Koji
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (20H03941)
- License Information
-
More Information
Article History
Received: 1 December 2021
Accepted: 10 March 2023
First Online: 22 March 2023
Declarations
:
: M.T. has received a consultation fee from Eisai Co., Ltd. M.Y. has received research grants from Astellas Pharma, Chugai Pharmaceutical, Daiichi Sankyo, Fujiyakuhin, Kyowa Hakko Kirin, Mitsubishi Tanabe Pharma, MSD KK, Nippon Boehringer Ingelheim and Torii Pharmaceutical. K.K. has received research funds from Eisai Co., Ltd.; Kyowa Kirin Co., Ltd.; Sumitomo Dainippon Pharma Co., Ltd.; Pfizer Inc.; Stella Pharma Corporation; CMIC Co., Ltd.; Suntory Beverage & Food Ltd.; Mitsubishi Corporation, and Real World Data Co., Ltd.; consulting fees from LEBER Inc.; JMDC Inc.; Shin Nippon Biomedical Laboratories Ltd.; Kaken Pharmaceutical Co., Ltd.; and Advanced Medical Care Inc.; executive compensation from Cancer Intelligence Care Systems; Inc.; an honorarium from Mitsubishi Chemical Holdings Corporation, Mitsubishi Corporation, and Pharma Business Academy; and holds stock in Real World Data Co., Ltd. KS declares no competing interests.
